Skip to main content
SpringerLink
Log in

A review of the properties of a new specific 5-HT reuptake inhibitor — fluvoxamine maleate

  • Chapter
Frontiers in Neuropsychiatric Research

Abstract

Some years back the Clinical Research Department of Duphar B.V. was presented with a new non-tricyclic compound which, pharmacologically, was characterized as an antidepressant with few side-effects. We attempted to confirm this activity in the clinic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cella, S., Penalva, A., Locatelli, V., Novelli, A., Cocchi, D., and Muller, E. E. (1982). Neuroendocrine studies with fluvoxamine: animal data. Brit.J.Clin.Pharm., 15:357S–364S

    Article  Google Scholar 

  • Claassen, V. (1983). The animal pharmacology and pharmacokinetics of fluvoxamine. Brit.J.Clin.Pharm., 15:349S–364S

    Article  CAS  Google Scholar 

  • Claassen, V., Davies, J. E., Hertting, G. and Placheta, P. (1977). Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Brt.J.Pharm., 60:505–516

    Article  CAS  Google Scholar 

  • Coppen, A. (1972). Indoleamines and affective disorders. J.Psychiat.Res., 9:163–171

    Article  PubMed  CAS  Google Scholar 

  • Davies, B. (1977). Problems of clinical research into affective disorders. In: G. Burrows (ed.), Handbook of Studies on Depression, Excerpta Medica, Amsterdam/London/New York, pp. 217–282

    Google Scholar 

  • De Wilde, J. E. M. and Doogan, D. P. (1982), Fluvoxamine and chlorimipramine in endogenous depression. J.Aff.Dis., 4:249–259

    Article  CAS  Google Scholar 

  • Dick, P. and Ferrero, E. (1983). A double-blind comparative study of clinical efficacy of fluvoxamine and clorimipramine. Brit.J.Clin.Pharm., 15:419S–425S

    Article  Google Scholar 

  • Feighner, J. P., Robinson, E., Quze, S. B., Woodruff, R. A., Winokur, G. and Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Arch.Gen.Psych., 26:56–73

    Article  Google Scholar 

  • Feldman, H. S. and Denber, H. O. B. (1982). Long term study of fluvoxamine: a new rapid acting antidepressant. Int.Pharmacopsych., 17:114–1221

    Google Scholar 

  • Guelfi, J. D., Dreyfus J. F., Pichot, P. and the G. E. P. E. C. E. P. (1983). A double-blind controlled trial comparing fluvoxamine with imipramine. Brit.J.Clin.Pharm., 15:411S–417S

    Article  Google Scholar 

  • Guy, W. (1976). In: ECDEU Assesment Manual, D.H.E.W. Publication no. 76–338, pp. 217–222

    Google Scholar 

  • Hamilton, M. (1967). Development of a rating scale for primary depressive illness. Brit.J.Soc.CLin.Psychol., 6:278–296

    Article  CAS  Google Scholar 

  • Herberg, K. W. and Menke, H. (1981). Studies of the effect of the antidepressant fluvoxamine on driving ability and its alcohol interaction. Durphar Report No. H.114.5074, Duphar BV, The Netherlands

    Google Scholar 

  • Itil, T. Bhattachyariya, A., Povan, N., Hugue, M. and Menon, G. N. (1977). Fluvoxamine (DU23000), a new antidepressant: Quantitative pharmaco-electro encepholography and pilot clinical trials. In: B. Saletu (ed.), Progress in Neuropsychopharmacology, vol. 1, Pergamon Press, Oxford/New York, pp. 309–322.

    Google Scholar 

  • Itil, T. M., Shrivastava, R. K., Makherjee, S., Coleman, B. and Michael, S. T. (1983). A double-blind placebo controlled study of fluvoxamine (DU23000) and imipramine in outpatients with primary depression. Brit.J.Clin.Pharm., 15:433S–438S

    Article  Google Scholar 

  • Kletzky, O. A., St. Michel, P., Mashchak, C. A. and Coleman, B. (1982). Acute effect of fluvoxamine, a new serotonin reuptake inhibitor, on hypothalamic-pituitary function. Eur.J. Clin.Pharm., (in press)

    Google Scholar 

  • Klok, C. J., Brouwer, H. M., Van Praag, H. M. and Doogan, D. (1981). Fluvoxamine and clomipramine in depressed patients, a double-blind clinical study. Acta Psychiat.Scand., 64: 1–11

    Article  PubMed  CAS  Google Scholar 

  • Lapierre, Y. D., Oyewumi, L. K. and Coleman, B. (1981). The efficacy of fluvoxamine as an antidepressant. Clin.Trials J., 18:5, 313–320

    Google Scholar 

  • Lapin, I. P. and Oxenkrug, G. F. (1969). Intensification of the central scrotonergic properties as a possible determinant of the thymoleptic effect. Lancet, i: 132–136

    Google Scholar 

  • Marks J. (1965). In J. Marks and Ø C. M. B. Pare (eds.), The Scientific Basis of Drug Therapy in Psychiatry, Pergamon Press, New York, pp. 103–113

    Google Scholar 

  • Robinson, J. F. and Doogan, D. P. (1982). A placebo controlled cardiotoxicity study of antidepressant drugs, fluvoxamine and clovoxamine in human volunteers. Brit.J.Clin.Pharmac., 14:805–808

    Article  CAS  Google Scholar 

  • Robles de Medina, E. O. (1972). A New Coding System for Electrocardiography, Excerpta Medica, Amsterdam, pp.63–99

    Google Scholar 

  • Saletu, B. Grunberger, J. Ranja, P. and Karobath, M. (1980). Clovoxamine and fluvoxamine — 2 biogenic amine reuptake inhibiting antidepressants: Quantitative EEG, Psychometric and Pharmacokinetic studies in man. J.Neurol.Trans., 49: 63–68

    Article  CAS  Google Scholar 

  • Saletu, B., Schjerve, M., Grunberger, J. and Schanda, A. O. H. (1977). Fluvoxamine — a new serotonin reuptake inhibitor: first clinical and psychometric experiences in depressed patients. J.Neurol.Trans., 41:17–36

    Article  CAS  Google Scholar 

  • Spencer, P. S. J. (1977). Review of the pharmacology of existing antidepressants. Brit.J.Clin.Pharm., 4:575–685

    Article  Google Scholar 

  • Wilson, W. H., Ban, T. A., Higano, Y. and Kelwala, S. (1983). A double-blind placebo-controlled comparison of the autonomic effects of fluvoxamine and those of amitriptyline and doxepin in healthy volunteers. Brit.J.Clin.Pharm., 15:385S–392S

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Head Clinical Psychotropic Research Group, Clinical Research Department, Duphar B. V., Weesp, Netherlands

    Jennifer S Wakelin

Authors
  1. Jennifer S Wakelin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry and Human Behavior, California College of Medicine, University of California, Irvine, USA

    Earl Usdin

  2. Department of Psychiatry, New York University School of Medicine, New York, USA

    Menek Goldstein , Arnold Friedhoff  & Anastasios Georgotas ,  & 

Copyright information

© 1983 The contributors

About this chapter

Cite this chapter

Wakelin, J.S. (1983). A review of the properties of a new specific 5-HT reuptake inhibitor — fluvoxamine maleate. In: Usdin, E., Goldstein, M., Friedhoff, A., Georgotas, A. (eds) Frontiers in Neuropsychiatric Research. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06689-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-06689-6_12

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-06691-9

  • Online ISBN: 978-1-349-06689-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation